Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 30, 2019

SELL
$22.67 - $35.0 $3.8 Million - $5.87 Million
-167,610 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$26.93 - $34.7 $3.77 Million - $4.86 Million
-139,935 Reduced 45.5%
167,610 $5.57 Million
Q4 2018

Feb 05, 2019

SELL
$27.23 - $45.56 $1.68 Million - $2.82 Million
-61,810 Reduced 16.73%
307,545 $8.94 Million
Q3 2018

Oct 29, 2018

SELL
$37.57 - $50.34 $1.13 Million - $1.51 Million
-30,070 Reduced 7.53%
369,355 $17 Million
Q2 2018

Aug 02, 2018

BUY
$27.75 - $40.17 $11.1 Million - $16 Million
399,425 New
399,425 $14.9 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.08B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Mesirow Financial Investment Management Equity & Fixed Income Portfolio

Follow Mesirow Financial Investment Management Equity & Fixed Income and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.